ncRNAs-mediated high expression of TICRR promotes tumor cell proliferation and migration and is correlated with poor prognosis and tumor immune infiltration of hepatocellular carcinoma.
ncRNAs-mediated high expression of TICRR promotes tumor cell proliferation and migration and is correlated with poor prognosis and tumor immune infiltration of hepatocellular carcinoma.
复制标题
DOI:
10.1016/j.omtn.2022.09.007
复制
发表时间:
2022-12-13
期刊:
影响因子:
--
通讯作者:
Guleng, Bayasi
中科院分区:
文献类型:
--
作者:
He, Ke-Jie;Zhang, Yang-fan;Liang, Lai-ying;Cheng, Xiao-Shen;Gong, Guoyu;Ouyang, Xiao-Mei;Lin, Ying;Guleng, Bayasi
TICRR is a regulatory factor of DNA replication with ToPBP1 interaction. At present, the underlying function and mechanisms of TICRR remain unclear in LIHC. Our objective was to assess the function and prognosis of TICRR in LIHC. We conducted a differential expression analysis, GO/KEGG, and GSEA enrichment analysis of TICRR in LIHC. We also carried out the gene frequency and SCNA of TICRR. We found that TICRR could serve as an independent prognostic marker in LIHC by univariate and multivariate analysis. In addition, we observed that TICRR was related to immune infiltration, and TICRR had positive correlation with PD1/PD-L1 and CTLA-4 in LIHC. The hsa-miR-126-3p/IPO9-AS1 may be the candidate ncRNAs to regulate the expression of TICRR. The high rate of SCNV of TICRR might have critical effect on the function of CTL cells in LIHC. We further demonstrate through a series of experiments that TICRR facilitated the proliferation and metastasis of liver cancer cells in vitro. Altogether, TICRR might be a potential biomarker and therapeutic target in LIHC. TICRR could serve as an independent prognostic marker in LIHC by univariate and multivariate analysis; TICRR was related to immune infiltration. TICRR facilitated the proliferation and metastasis of liver cancer cells in vitro. The hsa-miR-126-3p/IPO9-AS1 may be the candidate ncRNAs to regulate the expression of TICRR. TICRR might be a potential biomarker and therapeutic target in LIHC.
登录
查看更多内容
影响因子:
7.3
作者:
Gao J;Aksoy BA;Dogrusoz U;Dresdner G;Gross B;Sumer SO;Sun Y;Jacobsen A;Sinha R;Larsson E;Cerami E;Sander C;Schultz N
通讯作者:
Schultz N
影响因子:
64.5
作者:
Kalafati L;Kourtzelis I;Schulte-Schrepping J;Li X;Hatzioannou A;Grinenko T;Hagag E;Sinha A;Has C;Dietz S;de Jesus Domingues AM;Nati M;Sormendi S;Neuwirth A;Chatzigeorgiou A;Ziogas A;Lesche M;Dahl A;Henry I;Subramanian P;Wielockx B;Murray P;Mirtschink P;Chung KJ;Schultze JL;Netea MG;Hajishengallis G;Verginis P;Mitroulis I;Chavakis T
通讯作者:
Chavakis T
影响因子:
14.9
作者:
Li JH;Liu S;Zhou H;Qu LH;Yang JH
通讯作者:
Yang JH
影响因子:
30.5
作者:
Huang, Di;Chen, Xueman;Song, Erwei
通讯作者:
Song, Erwei
影响因子:
64.5
作者:
Liu J;Lichtenberg T;Hoadley KA;Poisson LM;Lazar AJ;Cherniack AD;Kovatich AJ;Benz CC;Levine DA;Lee AV;Omberg L;Wolf DM;Shriver CD;Thorsson V;Cancer Genome Atlas Research Network;Hu H
通讯作者:
Hu H